Member Info for Soupdragon78

Fairly even trades today, sells above mid price. Currenty 6.7055p to sell hence show as buys.

Scary, the NXP001 results will validate the NFX business model should they be good. Helps set up everything else to follow.

Doesn’t actually matter who he is, or whether he is from Poznan or Portishead.

And if there is a TR1 from Higgins increasing his holding?

There’s a difference between Q1 and H1

Plus we don’t know who Ebers Tech are, only that their website was set up the night before the NFX deal was announced.

Scary. There is no current link between NFX and Yatai’s cannabinoid side at the moment as far as I know. I just found it interesting that Yata, who through NSB have a partnership with NFX, are setting up a production line in Canada at the same time as NFX is looking to develop similar products. May be nothing but it shows there are opportunities.

Yaogen Chen, Chairman of Yatai Pharmaceutical, added: "This is a natural progression for Zhejiang Yatai and Benchmark Botanics as Benchmark's team already have experience in growing, cultivating and processing medical cannabis. We share the same principles as well as a philosophy rooted in science and geared for the production of unique, safe, and quality products. We've already established a multi-year plan and we're preparing our fully-equipped, state-of-the-art facility in Canada to capitalize the medical applications of CBD." The companies plan to establish a new joint venture company in Canada to fully integrate Zhejiang Yatai 's advantages in drug research and development, production and sales in the medical field and Benchmark's advantages in cannabis cultivation and extraction. All intellectual property developed in the research process in Canada will be owned by both companies, with commercialization planned in the countries where cannabis products are legal.

Cheers Aim. Knew there must be something somewhere.

This is one thing I can’t figure out, who is actually going to make the drug? Or whether that’s the next step. Newsummit are just a drug developer and not a manufacturer/producer. So presumably the will sell on the developed drug for their own percentage?

Phen, when you say 'results day' what do you mean? Year end?

Processing the test results is being done in the UK.

Potential is just that... potential. Until they get positive clearance on NXP001 then it’s speculation. No manipulation, just common sense.

So is still 50% up on its recent trading sub 2p Don’t know what people are fussing about.

It’s been easy enough to sell all day, which is unusual as usually this quickly goes NT when there is any substantial sells around. The last 1m showing is probs a buy given all buys at the time we’re the same price.

Breq, Ebers Tech website was created on Monday afternoon.

Investor1111, not the same Ebers.

www.eberstech.com

Porthleven, one key basic error in your post. NFX is not AIM listed, it’s main market listed. Other than that I’m sure your not a newbie.

Video posted on YouTube this evening ofDan Gooding at the investor event Biotech showcase https://youtu.be/oDL0laSJuAI